Akebia Therapeutics Funding: $115M Raised, IPO (2014)

Akebia Therapeutics funding overview

Akebia Therapeutics is based in Cambridge. Akebia Therapeutics has raised $115M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is an IPO announced in March 2014. The round record for Akebia Therapeutics runs through 2014; nothing later has been disclosed. Investors on record include BlackRock, DRX Capital, Venture Investors, Novartis, Athenian Venture Partners, Kearny Venture Partners and 9 others. 15 distinct backers are named across the disclosed rounds.

Akebia Therapeutics at a glance

Total raised: $115M
Latest round: IPO
Latest round date: March 2014
Headquarters: Cambridge
Notable investors: BlackRock, DRX Capital, Venture Investors, Novartis, Athenian Venture Partners, Kearny Venture Partners, Sigvion Capital, Triathlon Medical Ventures

Frequently asked about Akebia Therapeutics funding

How much has Akebia Therapeutics raised?: Akebia Therapeutics has raised $115M in total disclosed funding across the rounds on record.
Who has invested in Akebia Therapeutics?: BlackRock, DRX Capital, Venture Investors, Novartis, Athenian Venture Partners, Kearny Venture Partners are named among the investors backing Akebia Therapeutics.
What was the latest Akebia Therapeutics funding round?: The most recent disclosed round is an IPO, announced in March 2014.
Where is Akebia Therapeutics based?: Akebia Therapeutics is based in Cambridge.
When did Akebia Therapeutics last raise?: The last disclosed Akebia Therapeutics round closed in March 2014 at IPO.

We update the Akebia Therapeutics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Cambridge and their backers are listed below.

Akebia Therapeutics Funding: $115M Raised, IPO (2014)

Akebia Therapeutics funding overview

Akebia Therapeutics at a glance

Frequently asked about Akebia Therapeutics funding

Companies related to Akebia Therapeutics (36)

Browse related funding lists (6)